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ABSTRACT 
 
Trans Urethral Resection of the Prostate (TURP) is one of the gold operating standards for people with 
Benign Prostate Hyperplasia (BPH), but the complications, like bleedings, often occur both in durante and 
post-surgery. The risk of bleeding in TURP is caused by angiogenesis. Hypoxia-Induced Factor-1 Alpha (HIF-
1 α) is one of the trigger factors for angiogenesis in BPH. Based on the existing literature, it was found that 
there was a relationship between lycopene and dutasteride which both had a synergistic effect in inhibiting 
angiogenesis. However, the mechanism is unknown. This study aims to assess the effectiveness of the 
combination of dutasteride and lycopene on the expression of HIF-1α and hematocrit levels in BPH patients 
undergoing TURP surgery. This research was an experimental study with "Double-Blind Randomized 
Controlled Trial Post Test Only Design". The 22 patients were divided into 2 groups, namely T (dutasteride + 
lycopene), C (lycopene+plasebo), which were given every 24 hours for a minimum of 30 days until the TURP 
operation was carried out. The observation of HIF-1α expression used immunohistochemical methods. 
Different tests were conducted between the groups with Independent T-test. The result shows the 
combination of dutasteride and lycopene was not significant in reducing the HIF-1α expression, indicated 
by mean rank in the group (C) (= 21.60), group (T) (= 20.00). The results obtained from the Independent   
T-test were (p = 0.410), meaning the difference in HIF-1α expression between the 2 groups was not 
significant: Average Δ Ht group C (= 1.26); group T (= -0,98). The statistical test with the Independent T-test 
obtained (p = 0.027), where there were significant differences. Giving a combination of dutasteride and 
lycopene for at least 30 days pre-TURP surgery was not effective in reducing the expression of hypoxia-
induced factor - 1 alpha (HIF-1α) but was effective in reducing hematocrit levels compared to a single 
administration of dutasteride in BPH patients undergoing TURP surgery. 
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INTRODUCTION  
The main health problem for men over 50 
years is prostate enlargement, where the incidence 
increases with age. In the hospital education center 
in Indonesia, such as in the Kariadi Hospital 
Semarang, from 2008 to 2010, where there were 
patients with prostate enlargement as many as 
1,742 cases, consisting of 293 patients who 
underwent surgery, 229 hospitalized, and 1220 
outpatients; Cipto Mangunkusomo Hospital 
Jakarta about 462 cases; and in Soetomo Hospital 
Surabaya, where there were 1,948 cases of benign 
enlargement in the period 1993-2002 (Nugroho     
et al., 2015). 
BPH is a secondary cause of Lower Urinary 
Track Symptom in men and its incidence will 
increase with age. These complaints often result in  
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stress, anxiety, pain, and discomfort that can affect 
the quality of life of patients. Therefore one of the 
goals of BPH therapy is to improve the quality of 
life of patients. Intervention therapy is the golden 
standard for handling BPH is the Trans Urethral 
Resection of the Prostate (TURP). TURP is 
performed on BPH patients who do not respond to 
medical therapy and prostate size of 30-80mL 
(Berry et al., 1984, Fitzpatric et al., 2006, Hoffman 
et al., 2000). 
One of the complications of TURP is 
bleeding, which can occur during surgery and post-
surgery. The incidence of hematuria and clot 
retention after TURP is around 6-11% of cases, this 
will indirectly increase hospital costs, length of 
care and patient morbidity and mortality. Several 
attempts have been made to reduce TURP bleeding 
including the coagulation of surgical durante, 
catheter traction, catheter balloon position, drugs, 
and irrigation. (McVary et al., 2010) At benign 
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enlargement of the prostate, angiogenesis in the 
prostate area can be found which can cause easy 
bleeding when TURP is performed. Several studies 
have been developed to look for angiogenesis 
inhibitors, including using 5 α reductase inhibitors. 
These 5α reductase inhibitors can prevent prostate 
tissue growth and cause prostate cell apoptosis, 
thereby reducing the size and symptoms of LUTS in 
BPH cases, while also reducing expression of the 
Vascular Endothelial Growth Factor (VEGF) and 
Micro Vascular Density (MVD) on tissues sub 
epithelial prostate. (Pujari et al., 2016, Walsh et al., 
1998, Foley et al., 2003) 
Several studies on preoperative use of 
dutasteride in the same timeframe did not affect 
the MVD of prostate specimens nor on 
intraoperative bleeding. (Andriole et al., 2004) 
Other studies also found similar results that 
pretreatment 2 to 4 weeks with dutasteride did not 
significantly reduce blood loss during or after 
TURP compared with placebo, although there was 
a significant emphasis on intraprostatic DHT. 
(Rittmaster et al., 1996) Several other studies have 
reported similar findings and recommended that 
dutasteride be taken for a longer duration. (Zong et 
al., 2011) Other studies found a significant 
reduction in blood loss in the use of dutasteride 0.5 
mg for more than 4 weeks before surgery. 
Vascularity in prostate tissue, especially in the 
periurethral area decreases after using dutasteride 
0.5 mg for 6 weeks. (Hahn et al., 2007) 
In addition to drugs class 5 α reductase 
inhibitors, some substances such as lycopene 
which are potential compounds as anticancer and 
have strong antioxidant activity, besides that 
lycopene can suppress the initiation, progression 
and metastasis of various tumors by targeting 
many signaling molecules. In addition, Lycopene 
can inhibit several signal growth factors, including 
signaling Insulin-like Growth Factors (IGF), 
Vascular Endothelial Growth Factor (VEGF) signals, 
and Platelet-Derived Growth Factor (PDGF) which 
directly or indirectly result in decreased growth 
cells by inducing apoptosis, and inhibiting                 
the occurrence of angiogenesis. 
(Shanmugasundaram et al.,) Lycopene substances 
are abundant in red fruits including tomatoes. 
(Martov et al., 2008, Semenza et al., 2007) 
Some studies have also shown that lycopene 
can inhibit the expression of HIF-1 in in vivo and in 
vitro studies. Hypoxia inducible factor-1 alpha (HIF 
1α) is involved in many compensation pathways 
such as angiogenesis, glucose metabolism, survival 
and tumor development. (Winarsi et al., 2007) 
Based on the existing literature it was found 
that there was a relationship between lycopene 
and dutasteride which both had a synergistic effect 
in terms of inhibiting angiogenesis. The two agents 
will jointly reduce and inhibit some signal growth 
factors that directly and / or indirectly result in 
decreased cell growth by inducing apoptosis and 
inhibiting the occurrence of angiogenesis. In this 
study researchers used a combination of 
dutasteride 0.5 mg and lycopene 30 mg to reduce 
bleeding in BPH after TURP. One parameter in 
assessing the effectiveness of these two drugs in 
reducing blood vessel density and the extent of 
blood vessels after administration of these agents 
is HIF-1α and measuring the difference in 
reduction in hematocrit levels.  
 
METHODOLOGY 
Materials And Method 
This research is an experimental study with 
the design of "Double Blind Randomized Controled 
Post Test Only Design Trial". It was done by 
comparing changes in angiogenesis between BPH 
patients who underwent TURP surgery by 
assessing the expression of HIF 1 α  and levels of 
Hematocrit after single dutasetride 0.5 mg in the 
control group and a combination of dutasteride 0 5 
mg + lycopene 30 mg in the treatment group for a 
minimum of 30 days until the TURP operation is 
carried out. 
The research sample was BPH patients who 
came to polycinics urology, surgical emergency 
room, and urology inpatient room at Kariadi 
Hospital Semarang which was clinically and 
sonographically diagnosed as BPH and planned to 
undergo TURP surgery. The size of the sample 
according to WHO uses a sample size for two 
sample situations. The minimum sample size for 
each group is: 40 patients, with Confidence Interval 
(CI) 95%. (Febriansah et al., 2008) 
The sample in this study was divided into 2 
groups by random allocation: 
Group 1 (C) was taken from all male suffered 
from BPH who came to urology clinic, emergency 
room, and urology inpatient ward in Kariadi 
Hospital Semarang which was clinically and 
sonographically diagnosed as BPH and given 
dutasteride 0.5 mg once daily for at least 30 days 
before undergoing TURP surgery (control group). 
Group 2 (T) was taken from all male 
suffered from BPH who came to the urology clinic, 
emergency room, and urology inpatient ward in 
Kariadi Hospital Semarang which was clinically 
and sonographically diagnosed as BPH and given 
dutasteride therapy 0.5 mg once daily and 
lycopene capsules 30 mg once daily for at least 30 
days before undergoing TURP surgery (treatment 
group). 
After completion of treatment, the patient 
will undergo TURP surgery, and before the 
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operation, a hematocrit blood sample is taken. 
During TURP the prostate scraping tissue was 
carried out as much as 5-10 periurethra prostate 
scrapings and then performed anatomical 
pathology examination at the Anatomical 
Pathology Laboratory Diponegoro Medical 
University Semarang.  
Immunohistochemical examination of 
prostate scrapings specimens was performed to 
assess the expression of HIF 1α after treatment. 
HIF 1 α readings are carried out with the Olympus 
BX-41 light microscope by anatomical pathologists. 
the TURP procedure uses a 24-F resectoscope    
(Karl Storz, Tuttlingen, Germany). TURP irrigation 
uses distilled water and counts the amount of 
TURP durante irrigation, length of operation, 
amount of bleeding and the amount of prostate 
scraping tissue (Table I). Data from                    
research results that have been recorded are 
collected and processed using the SPSS v.15 
program. 
 
 
 
RESULT AND DISCUSSION  
Result 
This study was conducted on 22 BPH 
patients with urinary retention who will undergo a 
TURP procedure and have fulfilled the inclusion 
criteria and exclusion criteria. Where during the 
study period 2 subjects dropped out of the study, 
with details; 1 subject did not want to be operated 
(C group), and 1 subject dropped out because of the 
results of the Pathology Anatomy examination 
found a malignancy of the prostate (T group) so 
that subjects who qualified to continue the study 
were only 20 subjects. 
The results of the statistical test with the 
Independent T Test in the 2 groups were obtained 
(p = 0.410) which means that the difference in HIF-
1α between the treatment group (T) and the 
control group (C) was not significant. 
The results of the statistical test with 
Independent T Test in the 2 groups obtained                
p = 0.027, which means that the  difference  in  the 
 
Table I. Subject characteristics based on the study group (n = 20) 
 
Variabel Mean ± SD Median (min – max) p 
Age 65,35 ± 6,98 66,5 (51 – 80) 0,830§ 
Prostate Volume 43,66 ± 16,83 37,53 (25,45 – 86,03) 0,597‡ 
Duration of operation 22,75 ± 8,50 20 (15 – 40) 0,079‡ 
Duration of drug 
administration 
32,35 ± 2,11 32 (30 – 36) 0,179§ 
HIF-1α 20,80 ± 4,21 21 (14 – 28) 0,410§ 
Amount of irrigation 4600 ± 1187,66 5000 (3000 – 7000) 0,477‡ 
Duration of catheter 33,15 ± 1,46 34 (31 – 35) 0,345‡ 
Ht pre 39,43 ± 5,28 39,45 (30,1 – 49,9) 0,735§ 
Ht post 39,57 ± 5,41 40,5 (29,7 – 47,9) 0,574§ 
Difference of Ht 0,14 ± 2,33 -0,2 (-4,7 – 4,1) 0,027§* 
 
note : * Signifikan; § Independent t; ‡ Mann Whitney 
 
Table II. Average Percentage of HIF-1 in each group 
 
HIF-1α Mean ± SD P 
Treatment (T) 20,00 ± 2,83 
0,410§ 
control (C) 21,60 ± 5,30 
 
note: § Independent t 
 
Table III. Average Δ Data on HT levels in each group 
 
Treatment Mean  SD p 
C 1,26 ± 1,99 
0,027§* 
T -0,98 ± 2,16 
 
note : * Signifikan p < 0,05, § Independent t 
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decrease in Ht levels pre and postoperatively in the 
2 groups was significant. 
 
Disscussion 
Previous research suggests that agent 5α 
reductase inhibitors (dutasteride) are said to 
reduce the expression of hypoxia induced factor - 1 
alpha (HIF-1α) in the sub epithelial tissue of the 
prostate. (Upadhyay et al., 2009) Theoretically 
hypoxia is thought to be the most potent stimulant 
of VEGF, and its expression transcriptional is 
regulated by HIF - 1. The role of HIF-1 is very 
important, as a regulator of genomic transcription 
is widely identified for O2 hemostasis in response 
to hypoxic stress. HIF-1 is a heterodimer consisting 
of HIF-1α and HIF-1β subunits. HIF-1 β is 
expressed constitutively, where HIF-1 α 
expression is maintained at a low level in most cells 
under normal conditions. (Ku et al., 2009) 
Under hypoxic conditions, HIF-1 α releases 
proteosomal degradation and is then translocated 
to the nucleus. The process formed as a result of 
the inhibition of oxygen-dependent 
prolylhydroxylase activity modifies 564 and 402 
residues, and the subsequent process is mediated 
by cell nucleus localization signals. This enzymatic 
modification of HIF-1 α is needed to bind the von 
hippel-lindau protein, which recognizes the 
component of the ubiquitin E3 protein ligase which 
is the target of HIF-1 α for proteosomal 
degradation. In contrast to the regulation of oxygen 
dependence from degradation of HIF-1 α, it is 
reported that factors that induce synthesis of HIF-
1 α proteins via signal transduction pathway lead 
to tyrosine kinase to PI3K receptors to AKT and 
FRAP serine / threonine kinase. (Upadhyay et al., 
2009, Ku et al., 2009) 
The results of statistical tests showed that 
there was no significant difference in the 
expression of HIF-1α in the treatment group (P) 
given a combination of dutasteride and lycopene 
with the control group (K) which was only given 
dutasteride alone (table II). Previous studies have 
found that preoperative use of dutasteride over a 
period of 2-4 weeks did not affect the MVD of 
prostate specimens nor in intraoperative bleeding. 
(Zong et al., 2011) Other studies also found similar 
results that pretreatment 2 to 4 weeks with 
dutasteride did not significantly reduce blood loss 
during or after TURP compared with placebo, 
although    there was a significant emphasis on 
intraprostatic DHT.15 Several other studies have                     
reported similar findings and recommended        
that dutasteride be taken for a longer duration. 
(Shanmugasundaram et al., 2007). 
 
TURP (Transurethral Resection of Prostate) 
is still the gold standard for handling cases of BPH. 
The most common complications are intra and 
perioperative bleeding. However, the bleeding is 
expected to be reduced by administering a 
combination of lycopene and dutasteride.                
The results of statistical tests regarding the 
differences in hematocrit levels pre and 
postoperatively between groups were found in the 
treatment group (P) there was less decline when 
compared to the control group (K) (Table III). 
There are several factors that can affect the 
reduction of hematocrit in post-TURP surgery in 
this study, including the duration of action and 
fluid balance. Research conducted by Ather et al., . 
Found   that  bleeding  that  occurred  during  TURP 
 was influenced by length of operation and prostate 
size. Research conducted by Kirollos et al., also 
suggested that the size of the prostate affected 
bleeding during TURP surgery. (Kirolls et al., 1997) 
Research conducted by Miyao et al., found that 
there were differences in hematocrit in the group 
with TURP syndrome with asymptomatic ones. 
This decrease in hematocrit is assumed to occur 
due to hemodilution during TURP surgery which is 
also affected by the duration of surgery. (Miyao       
et al., 2001) 
Pastore et al., found a significant reduction 
in hematocrit for dutasteride for 6 weeks. 
However, in a study conducted by Hahn RG et al., 
there was no significant difference in blood loss 
between the dutasteride group and the untreated 
group. (Winarsi et al., 2007) Results conducted by 
Boccon-Gilbod L et al., concluded that differences 
in blood loss in patients given dutasteride 
previously for 4 weeks compared to the untreated 
group after TURP showed insignificant results. The 
insignificant results are assumed to occur because 
they are influenced by the duration of 
administration of therapy which affects the 
decrease in hematocrit in TURP surgery.        
(Boccon et al., 2005). 
 
CONCLUSION 
Giving a combination of dutasteride and 
lycopene for at least 30 days pre TURP surgery was 
not effective in reducing the expression of Hypoxia 
Induced Factor-1 alpha (HIF-1α) in BPH patients 
who underwent TURP surgery but significantly 
reduced post-TURP hematocrit levels when 
compared with single dutasteride. There were no 
smaller HIF 1-alpha expressions in the group given 
a combination of dutasteride and lycopene than the 
group given dutasteride single. There were 
differences  in the smaller   post  TURP  hematocrit 
Efficacy of Combination Dutasteride and Lycopene to Reduce Bleeding 
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values in the group given a combination of 
dutasteride and lycopene compared to the group 
given single dutasteride. 
 
SUGGESTION 
It is recommended to extend the duration of 
treatment before the TURP procedure, increase the 
number of samples, use a combination of effective 
dutasteride and lycopene doses, see long-term side 
effects on the combination use of dutasteride and 
lycopene, see the effectiveness of decreasing 
angiogenesis from a combination of dutasteride 
and lycopene against other angiogenic receptors, 
and see a relationship between factors that 
influence TURP procedure for postoperative 
bleeding. 
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